Drug intelligence / Profile preview

CS-DIVICARE

Development stage: Preclinical
Lead developer: DreemBio
Modality: Small Molecules

Overview

CS-DIVICARE is a phytotherapeutic (plant-based) drug candidate currently in development by DreemBio. It is designed to address multiple therapeutic areas, including COVID-19, breast cancer, and Acute Myeloid Leukemia (AML). As a phytomedicine, CS-DIVICARE utilizes standardized botanical extracts that contain a complex mixture of bioactive secondary metabolites. These compounds are intended to provide a multi-targeted approach to disease management, potentially modulating various biological pathways involved in viral pathogenesis and oncogenesis. The asset is part of DreemBio's broader effort to validate traditional medicinal knowledge through modern pharmacological standards.

Other names: CS-DIVICARE-DreemBio-phytomedicine-phytotherapeutic-COVID-19-breast cancer-Acute Myeloid LeukemiaCS-DIVICARE-DreemBio-phytomedicine-phytotherapeutic-COVID19-breast cancer-Acute Myeloid LeukemiaCS-DIVICARE-DreemBio-phytomedicine-phytotherapeutic-COVID 19-breast cancer-Acute Myeloid Leukemia

Beyond the preview

Go deeper on CS-DIVICARE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CS-DIVICARE.

Explore the full profile